SCHEMBL6975276

SCHEMBL6975276

CNc1nc(N)nc(-c2ccc(-c3ccccc3)cc2)n1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 3/20 0.60
ADORA1 P30542 3/20 0.60
ADORA3 P0DMS8 2/20 0.60
ADORA2B P29275 2/20 0.60
POLB P06746 1/20 0.60
NPSR1 Q6W5P4 1/20 0.59
HSP90AA1 P07900 1/20 0.51
HSP90AB1 P08238 1/20 0.51
TPH1 P17752 4/20 0.49
HRH4 Q9H3N8 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
TRIM58 Q8NG06 1/20 0.46
ALOX15 P16050 1/20 0.46
TSHR P16473 1/20 0.46
GPR68 Q15743 3/20 0.46
HTR1A P08908 1/20 0.46
NUDT1 P36639 1/20 0.44
ALDH1A1 P00352 2/20 0.43
MEN1 O00255 1/20 0.43
MAPT P10636 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL527618 0.96 ADORA2A (0.64) ADORA2AADORA1ADORA3ADORA2BPOLB
SCHEMBL6978463 0.87 TDP1 (0.57) ADORA2AADORA1ADORA3ADORA2BPOLB
SCHEMBL24218050 0.83 TDP1 (0.61) ADORA2AADORA1ADORA3ADORA2BPOLB
SCHEMBL1030285 0.83 TDP1 (0.61) ADORA2AADORA1ADORA3ADORA2BPOLB
SCHEMBL6334237 0.81 ADORA1 (0.82) ADORA2AADORA1ADORA3ADORA2BPOLB
SCHEMBL6977514 0.81 ADORA1 (0.91) ADORA2AADORA1ADORA3ADORA2BPOLB
SCHEMBL18057759 0.81 ADORA1 (0.82) ADORA2AADORA1ADORA3ADORA2BPOLB
SCHEMBL14058517 0.80 ADORA2A (0.67) ADORA2AADORA1ADORA3ADORA2BPOLB
SCHEMBL6982880 0.80 TPH1 (0.56) ADORA2AADORA1ADORA3ADORA2BPOLB
SCHEMBL17840534 0.79 NPSR1 (0.73) ADORA2AADORA1ADORA3ADORA2BPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1037886-B1 TRIAZINE ANGIOGENESIS INHIBITORS ABBOTT LAB (US) 2003-05-02 EP claimed
US-6150362-A ADMINISTERING 1,3,5-SUBSTITUTED TRIAZINE COMPOUNDS TO THE PATIENT SUFFERING FROM ANGIOGENIC DISEASES ABBVIE INC. 2000-11-21 US claimed
EP-1037886-A1 TRIAZINE ANGIOGENESIS INHIBITORS Abbott Laboratories (US) 2000-09-27 EP claimed
WO-1999031088-A1 TRIAZINE ANGIOGENESIS INHIBITORS ABBOTT LABORATORIES (US) 1999-06-24 WO claimed
EP-1037886-B1 TRIAZINE ANGIOGENESIS INHIBITORS ABBOTT LAB (US) 2003-05-02 EP disclosed
US-6288228-B1 DIAMINOTRIAZINE DERIVATIVES ABBOTT LABORATORIES 2001-09-11 US disclosed
US-6150362-A ADMINISTERING 1,3,5-SUBSTITUTED TRIAZINE COMPOUNDS TO THE PATIENT SUFFERING FROM ANGIOGENIC DISEASES ABBVIE INC. 2000-11-21 US disclosed